enVVeno Medical (NASDAQ: NVNO) — Company Overview, News & Financial Data
enVVeno Medical develops pioneering devices for venous diseases, focusing on innovative and minimally invasive treatments.
enVVeno Medical
enVVeno Medical (NASDAQ:NVNO) specializes in pioneering medical devices designed to advance the treatment of venous diseases. A primary focus of enVVeno Medical is on developing innovative solutions that can significantly improve the quality of life for patients suffering from such conditions. Their projects are diverse, ranging from early-stage research to the commercialization of products aimed at addressing venous insufficiencies. Objectives for enVVeno Medical include pushing the boundaries of medical technology to provide effective, minimally invasive treatments, expanding their product portfolio to cover a wider range of venous disease treatments, and establishing strong market presence globally. Through cutting-edge research and development, enVVeno Medical is committed to advancing healthcare for those afflicted by venous diseases.
Snapshot
Operations
Products and/or services of enVVeno Medical
- Venous Disease Product Line: Innovative solutions targeting chronic venous insufficiency, improving patient outcomes.
- Medical Devices: Cutting-edge devices designed for the treatment of varicose veins, enhancing procedural efficiency and safety.
- Compression Therapy Solutions: Advanced compression therapy products to aid in the recovery and management of venous disorders.
- Diagnostic Tools: High-tech diagnostic equipment for accurate assessment of venous conditions, facilitating targeted treatments.
- Educational Programs: Comprehensive educational resources for healthcare professionals, focusing on the latest techniques in venous disease treatment.
enVVeno Medical executive team
- Robert A. BermanCEO & Director
- Jennifer BrightChief Financial Officer
- Hamed AlaviSenior VP & Chief Technology Officer
- Marc H. GlickmanSenior VP & Chief Medical Officer
- Sandy PriettoVice President of Marketing
- Avi SharmaSenior Vice President of Clinical, Regulatory & Quality
Latest news about enVVeno Medical
Key financials
Reported results for enVVeno Medical , in USD.
- Market cap
- 4.8M
- Revenue (TTM)
- 0
- P/E ratio
- —
- EPS (diluted, TTM)
- -23.3
- Dividend yield
- —
- Profit margin
- 0.0%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 0 | -20.9M | -19.5M | |
| 0 | -23.8M | -21.8M | |
| 0 | -25.2M | -23.5M | |
| 0 | -24.9M | -24.7M |